Alexander GC, Frattaroli S, Gielen AC, editors. The Prescription Opioid Epidemic: An Evidence-Based Approach. Baltimore: Johns Hopkins Bloomberg School of Public Health; 2015.
Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241–8.
Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–74.
Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–82.
Center for Behavioral Health Statistics and Quality. Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. In: HHS Publication No. SMA 16–4984, NSDUH Series H-51. Rockville: Substance Abuse and Mental Health Services Administration; 2016.
Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, Schein JR, Katz NP. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective. Clin J Pain. 2006;22(8):667–76.
Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):657–67.
Meyer R, Patel AM, Rattana SK, Quock TP, Mody SH. Prescription opioid abuse: a literature review of the clinical and economic burden in the United States. Popul Health Manag. 2014;17(6):372–87.
Rice JB, Kirson NY, Shei A, Cummings AK, Bodnar K, Birnbaum HG, Ben-Joseph R. Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data. Appl Health Econ Health Policy. 2014;12(4):435–46.
Roland CL, Joshi AV, Mardekian J, Walden SC, Harnett J. Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States. J Opioid Manag. 2013;9(3):161–75.
Shei A, Hirst M, Kirson NY, Enloe CJ, Birnbaum HG, Dunlop WC. Estimating the health care burden of prescription opioid abuse in five European countries. Clinicoecon Outcomes Res. 2015;7:477–88.
White AG, Birnbaum HG, Mareva MN, Daher M, Vallow S, Schein J, Katz N. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005;11(6):469–79.
Yang Z, Wilsey B, Bohm M, Weyrich M, Roy K, Ritley D, Jones C, Melnikow J. Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid. J Pain. 2015;16(5):445–53.
White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care. 2009;15(12):897–906.
Dufour R, Mardekian J, Pasquale MK, Schaaf D, Andrews GA, Patel NC. Understanding predcitors of opioid abuse: predictive model development and validation. Am J Pharm Benefits. 2014;6(5):208–16.
White AG, Birnbaum HG, Schiller M, Waldman T, Cleveland JM, Roland CL. Economic impact of opioid abuse, dependence, and misuse. Am J Pharm Benefits. 2011;3(4):e59–70.
Pasquale MK, Joshi AV, Dufour R, Schaaf D, Mardekian J, Andrews GA, Patel NC. Cost drivers of prescription opioid abuse in commercial and Medicare populations. Pain Pract. 2014;14(3):E116–25.
Cochran BN, Flentje A, Heck NC, Van Den Bos J, Perlman D, Torres J, Valuck R, Carter J. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014;138:202–8.
Braden JB, Russo J, Fan MY, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med. 2010;170(16):1425–32.
Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174(5):796–801.
Cicero TJ, Wong G, Tian Y, Lynskey M, Todorov A, Isenberg K. Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. Pain. 2009;144(1–2):20–7.
Analyzing Prescription Data and Morphine Milligram Equivalents [https://www.cdc.gov/drugoverdose/resources/data.html]. Accessed 02 May 2018.
Chang HY, Murimi IB, Jones CM, Alexander GC. Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers. Addiction. 2018;113(4):677–86.
Chang HY, Murimi I, Faul M, Rutkow L, Alexander GC. Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis. Pharmacoepidemiol Drug Saf. 2018;27(4):422–9.
Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171(7):686–91.
Jones CM, McAninch JK. Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med. 2015;49(4):493–501.
Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698.
McAdam-Marx C, Roland CL, Cleveland J, Oderda GM. Costs of opioid abuse and misuse determined from a Medicaid database. J Pain Palliat Care Pharmacother. 2010;24(1):5–18.
Rice JB, White AG, Birnbaum HG, Schiller M, Brown DA, Roland CL. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 2012;13(9):1162–73.
Chang HY, Boyd CM, Leff B, Lemke KW, Bodycombe DP, Weiner JP. Identifying consistent high-cost users in a health plan: comparison of alternative prediction models. Med Care. 2016;54(9):852–9.
Chang HY, Clark JM, Weiner JP. Morbidity trajectories as predictors of utilization: multi-year disease patterns in Taiwan's national health insurance program. Med Care. 2011;49(10):918–23.
Chang HY, Lee WC, Weiner JP. Comparison of alternative risk adjustment measures for predictive modeling: high risk patient case finding using Taiwan's National Health Insurance claims. BMC Health Serv Res. 2010;10:343.
Chang HY, Weiner JP. An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan. BMC Med. 2010;8:7.
Starfield B, Hankin J, Steinwachs D, Horn S, Benson P, Katz H, Gabriel A. Utilization and morbidity: random or tandem? Pediatrics. 1985;75(2):241–7.
Starfield B, Weiner J, Mumford L, Steinwachs D. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991;26(1):53–74.
Weiner JP, Starfield BH, Steinwachs DM, Mumford LM. Development and application of a population-oriented measure of ambulatory care case-mix. Med Care. 1991;29(5):452–72.
Chang HY, Richards TM, Shermock KM, Elder Dalpoas S, J Kan H, Alexander GC, Weiner JP, Kharrazi H. Evaluating the Impact of Prescription Fill Rates on Risk Stratification Model Performance. Med Care. 2017;55(12):1052–60.
Chang HY. The impact of morbidity trajectories on identifying high-cost cases: using Taiwan's National Health Insurance as an example. J Public Health. 2014;36(2):300–7.
Reid RJ, Roos NP, MacWilliam L, Frohlich N, Black C. Assessing population health care need using a claims-based ACG morbidity measure: a validation analysis in the Province of Manitoba. Health Serv Res. 2002;37(5):1345–64.
Forrest CB, Lemke KW, Bodycombe DP, Weiner JP. Medication, diagnostic, and cost information as predictors of high-risk patients in need of care management. Am J Manag Care. 2009;15(1):41–8.
Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.
Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–94.
Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, Little F, Maartens G. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med. 2009;6(12):e1000189.
Nguyen H, Ivers R, Jan S, Pham C. Analysis of out-of-pocket costs associated with hospitalised injuries in Vietnam. BMJ Global Health. 2017;2(1):e000082.
Shen Y, Ellis RP. How profitable is risk selection? A comparison of four risk adjustment models. Health Econ. 2002;11(2):165–74.
Leider HL, Dhaliwal J, Davis EJ, Kulakodlu M, Buikema AR. Healthcare costs and nonadherence among chronic opioid users. Am J Manag Care. 2011;17(1):32–40.
Ghate SR, Haroutiunian S, Winslow R, McAdam-Marx C. Cost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: a comparison of two recently published studies. J Pain Palliat Care Pharmacother. 2010;24(3):251–8.
Deyo RA, Hallvik SE, Hildebran C, Marino M, Dexter E, Irvine JM, O'Kane N, Van Otterloo J, Wright DA, Leichtling G, et al. Association between initial opioid prescribing patterns and subsequent long-term use among opioid-naive patients: a statewide retrospective cohort study. J Gen Intern Med. 2017;32(1):21–7.
Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use – United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66(10):265–9.
Barnett ML, Olenski AR, Jena AB. Opioid-prescribing patterns of emergency physicians and risk of long-term use. N Engl J Med. 2017;376(7):663–73.
Kim H, Hartung DM, Jacob RL, McCarty D, McConnell KJ. The concentration of opioid prescriptions by providers and among patients in the Oregon Medicaid Program. Psychiatr Serv. 2016;67(4):397–404.
Chang HY, Lyapustina T, Rutkow L, Daubresse M, Richey M, Faul M, Stuart EA, Alexander GC. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysis. Drug Alcohol Depend. 2016;165:1–8.
Rutkow L, Chang HY, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on opioid prescribing and use. JAMA Intern Med. 2015;175(10):1642–9.
Rago G. Overdose to ER, a ‘Warm Handoff’ could save lives: USA Today; 2017. https://www.ydr.com/story/news/2017/03/29/overdose-er-warm-handoff-could-save-lives/99736074/. Accessed 02 May 2018.
Medication-Assisted Treatment Data. http://preventoverdoseri.org/medication-assisted-therapy/. Accessed 02 May 2018.
Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study. Ann Intern Med. 2016;164(1):1–9.
Daubresse M, Saloner B, Pollack HA, Alexander GC. Non-buprenorphine opioid utilization among patients using buprenorphine. Addiction. 2017;112(6):1045–53.